An independent source of information on U.S. brand name drugs for health professionals

Drugdocs Logo

An independent source of information on U.S. brand name drugs for health professionals

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Motegrity

Chemical Nameprucalopride
Dosage FormTablet (oral; 1 mg, 2 mg)
Drug ClassReceptor agonists
SystemDigestive
CompanyShire LLC
Approval Year2018

Indication

  • To treat chronic idiopathic constipation in adults.
Last updated on 11/5/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Motegrity (Prucalopride) Prescribing Information 2018Shire LLC, Lexington, MA
Document TitleYearSource
Efficacy of drugs in chronic idiopathic constipation: A systematic review and network meta-analysis. 2019The Lancet. Gastroenterology & Hepatology
Document TitleYearSource
Clinical practice guidelines from the French National Society of Coloproctology in treating chronic constipation. 2018European Journal of Gastroenterology & Hepatology